|
(2007, 2000 words)
The project proposal would analyse the market of high-potency drug market in terms of the market dynamics, economics and competitive landscape. It would also try to examine the merit of investing in more up-to-date technology to produce high-potency drugs for the market.
(2007, 2000 words)
In May 2004, 10 new countries joined the European Union (EU), thereby increasing the member states from 15 to 25. A number of key factors can be identified as having the greatest impact on the UK pharmaceutical industry during the post-accession of these states. This report has been aimed at analyzing these impacts of EU enlargement on the overall UK pharmaceutical industry.
(2007, 12 slides)
The power point presentation discusses the collaborative strategies in Pharmaceutical Industry
(2007, 8500 words)
The paper examines the role of innovation and imitation of other firms in the development of an organization providing a review of academic literature on the types of innovation, the theory of uncertainty and decision making, knowledge diffusion, etc. Innovation in the pharmaceutical industry is analysed outlining the challenges of pharmaceutical manufacturing, the relationships between scientific research and industrial innovation, the issues of intellectual property, pharmaceutical market structure, incentives for innovation, etc.
(2006, 10 500 words)
The dissertation investigates the performance of GlaxoSmithKline (GSK) form their pre-merger through to the post merger periods providing a review of literature on the theory of mergers and acquisitions (M&A), an overview of the pharmaceutical industry and GSK background including their financial and operational review, performance analysis, etc. The methods of research are based on primary (interviews) and secondary data sources. Conclusions are made about the pre and post merger financial, operational, and value creation performance of GSK.
(2006, 1500 words)
The paper reports on the pharmaceutical company Pfizer offering an overview of the industry environment and the development of pharmaceutical products. Analysis is conducted of Pfizer's micro-environment discussing their Marketing Mix features and suggesting recommendations about the company's business and financial strategies.
(2006, 2500 words)
The paper examines the macro environment of the pharmaceutical industry conducting its STEP (PEST) analysis and identifying market trends within the industry. Analysis of the Indian pharmaceutical industry is conducted using the models of Porter's Five Forces and Generic Strategies.
(2006, 2500 words)
The paper addresses the problem of drug trafficking under globalization reviewing the situation in the world drug market, the US war on drugs, etc. Medical and social consequences of illicit drug use are outlined and discussed.
(2005, 6000 words)
This paper examines the Global Pharmaceutical industry's overview, sales, regional forecasts and size. The macro-environment through PESTEL while the industry structure is analyzed with the help of Porter's Five Forces. The analysis of GSK, the world's biggest pharmaceutical company, will be presented through a SWOT that will help us understand what is at stake. Merger and post merger problems COMPLEXITY: THE NATURE OF REAL WORLD PROBLEMS and the Paradox formations. This paper is based on the case study from the book by Johnson and Scholes "Exploring Corporate Strategy: text and cases".
(2006, 1950 words)
This paper examines trends in the macro-environment through PESTEL while the industry structure is analysed with the help of Porter’s Five Forces. The analysis of Pfizer, the world’s biggest pharmaceutical company, will be presented through a SWOT that will help us understand what is at stake.
(2006, 4500 words)
The paper reports on the pharmaceutical company GlaxoSmithKline (GSK) presenting an overview of the pharmaceutical industry, discussing the role of research and development (R&D) departments for pharmaceutical companies, etc. The history of GSK mergers is reviewed providing a critical analysis of the merger process and outlining future opportunities and threats.
(2006, 3000 words)
The paper reports on the pharmaceutical industry discussing the implications of the global regulatory approval, the role of ÓblockbusterÔ drugs, the rising costs of research and development projects, the generic drugs competition, etc. Forecasts are made suggesting various scenarios of the industry development.
(2006, 2000 words)
The paper examines the causes of the difficulty in developing new drugs reviewing the current problems in the pharmaceutical industry related to the patent system, the emergence of new competitors, the ÑblockbusterÒ model, the complexity of the research and development (R&D) process, the role of the government, etc.
(2006, 2400 words)
This essay links the underlying industry structure with its competitive environment and potential strategic routes available for a firm within the industry. In order to achieve the objective of this essay Pharmaceutical Industry has been used as a case study to understand the dynamics governing the structure of the industry. The essay has adopted one of the most widely used models in the business studies, Porters Five Forces as its key framework for the purpose of analysis.
(2005, 5000 words)
The paper investigates the M&A (mergers and acquisitions) transactions between the pharmaceutical and biotechnology companies providing an overview of the business, social and legal aspects of the pharmaceutical industry, and focusing on the acquisition of Pharmacia by Pfizer.
(2004, 3000 words)
This report will analyse different topics related to international business strategy, covering market analysis, trade and foreign direct investment theories, choices of strategy and structure of firms and finally, international HRM. Owing to the recent trends of Globalisation, the pharmaceutical industry draws the perfect picture to discuss and develop these topics. For this purpose and to narrow the research in the pharmaceutical industry, Switzerland will be considered as the home country with particular emphasis on Novartis. Nowadays, Switzerland has liberal trade and investment policies and is a member of the World Trade Organisation (WTO). Financial services, Pharmaceuticals and Tourism account for the majority of the GDP. The project will take place with the description of a macro-environment using the PEST analysis, then an understanding of the Swiss trading trends according to Porter's diamond theory, followed by an overview of the different penetration and foreign investments using the example of the Novartis experience which will lead to the identification of strategic choices. Finally a brief look at the strategy adopted by Human Resources management
(2004, 4000 words)
The paper is devoted to the study of market entry strategies. The author proceeds from general definitions of business strategies on to a case study analysing the performance of Boots, a British pharmaceutical company, in the Japanese market. Political, economic, cultural and technological factors affecting the markets are discussed; modes of entering a foreign market are outlined. An overview of the Japanese market is presented; Boots performance is evaluated using SWOT analysis.
(2005, 2000 words)
The paper reports on the profile of pharmaceutical industry focusing on the complementary medicines market. An overview of the industry and the analised segment is given; the performance of a company operating in the market is discussed within the frameworks of website and packaging analysis highlighting the strengths and weaknesses of its marketing policy.
(2004, 2500 words)
The paper investigates the reasons for the declining market share of Beta-Care, a UK company that operates within the pharmaceutical industry and specialises in medical diagnostic equipment. The paper claims that changes in eating, working and exercise patterns are leading to the growth of diabetes. Diabetes segments the market into Type 1 and Type 2; the Type 2 market includes the elderly people of African or Asian origin living in the UK, mostly the overweight and pregnant women. This is the target group for Beta-Care because they must pay for the equipment, which might give the company an opportunity to recover. The author performs SWOT analysis of Beta-Care; brands, prices, budget and channels to the market are analysed. The paper ends up with recommendations for the company's re-generation.
(2003, 7000 words)
This report presents the detailed investigation of the global pharmaceutical industry and analyses the ways in which technological innovation and issues of corporate social responsibility affect the industry. Report consists of the following sections: pharmaceutical industry analysis, pricing strategies, Research and Development in pharmaceutical industry, factors, which affect the companies operating in the industry, types of innovations (internal and external) in the industry future challenges, issues of corporate social responsibility which affect the industry and recommendations onto future development of the industry and companies.
(2004, 2000 words)
The aim of the research is to explore the necessary and complementary relationship between total quality and strategic management. Followed by the investigation of the role of quality management (QM) in GSK and how its implementation can be or planned to be improved by the company. The research will also aim to: Outline the links in between quality and strategy in pharmaceutical industry identifying why are they of such a particular concern to the industry and players (including GSK) within it? Follow the historic development of the link in between quality and strategy - what has changed over the decades? What is Quality Management/Total Quality Management in the pharmaceutical sector? What is its significance? Outline the role, procedures and stances of quality management in GSK, tracking the changes within them over the past two decades paying particular interest to the mergers of 1995 and 2000? Learn about and analyse the future trends in the quality management for pharmaceutical sector and GSK in particular from academic and practical sources. Compare and contrast results making conclusions and recommendations for the future. Possibly outline any threats or opportunities for the company, arising from the findings and analysis.
(2003, 1500 words)
Page 2>
|
